Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial

BMJ : British Medical Journal
Allen DietrichPaul Nutting

Abstract

To test the effectiveness of an evidence based model for management of depression in primary care with support from quality improvement resources. Cluster randomised controlled trial. Five healthcare organisations in the United States and 60 affiliated practices. 405 patients, aged > or = 18 years, starting or changing treatment for depression. Care provided by clinicians, with staff providing telephone support under supervision from a psychiatrist. Severity of depression at three and six months (Hopkins symptom checklist-20): response to treatment (> or = 50% decrease in scores) and remission (score of < 0.5). At six months, 60% (106 of 177) of patients in intervention practices had responded to treatment compared with 47% (68 of 146) of patients in usual care practices (P = 0.02). At six months, 37% of intervention patients showed remission compared with 27% for usual care patients (P = 0.014). 90% of intervention patients rated their depression care as good or excellent at six months compared with 75% of usual care patients (P = 0.0003). Resources such as quality improvement programmes can be used effectively in primary care to implement evidence based management of depression and improve outcomes for patients with depression.

References

Mar 1, 1979·Journal of Affective Disorders·R S LipmanA K Shapiro
Apr 5, 1995·JAMA : the Journal of the American Medical Association·W KatonJ Russo
Dec 14, 1994·JAMA : the Journal of the American Medical Association·R L SpitzerJ G Johnson
Jan 14, 2000·JAMA : the Journal of the American Medical Association·K B WellsL V Rubenstein
Jun 7, 2000·Journal of General Internal Medicine·D E Ford
Oct 24, 2000·JAMA : the Journal of the American Medical Association·J M Eisenberg, E J Power
Sep 15, 2001·Journal of General Internal Medicine·K Rost, J Smith
Oct 27, 2001·BMJ : British Medical Journal·M Von Korff, D Goldberg
Feb 14, 2002·Journal of General Internal Medicine·Paul A NuttingBeth Gallovic
Oct 26, 2002·BMJ : British Medical Journal·Kathryn RostMiriam Dickinson
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Jürgen UnützerUNKNOWN IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment
Jan 22, 2003·Journal of General Internal Medicine·Susan C HedrickWayne Katon
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Simon GilbodyRuth Thomas
Nov 26, 2003·The American Journal of Psychiatry·Enkhe BadamgaravJoshua J Ofman
Jan 24, 2004·BMJ : British Medical Journal·Richard Lewis, Jennifer Dixon
Feb 7, 2004·BMJ : British Medical Journal·Ray Moynihan
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Martha L BruceGeorge S Alexopoulos
Apr 17, 2004·BMJ : British Medical Journal·Sheila Leatherman, Kim Sutherland
Sep 1, 2004·Annals of Family Medicine·Allen J DietrichSheila L Barry

❮ Previous
Next ❯

Citations

Nov 26, 2005·International Archives of Occupational and Environmental Health·Judith BrownEwan B Macdonald
Oct 11, 2005·Administration and Policy in Mental Health·Harold Alan PincusJeanine Knox Houtsinger
Oct 11, 2005·Administration and Policy in Mental Health·Bruce L RollmanHerbert C Schulberg
Oct 11, 2005·Administration and Policy in Mental Health·Brenda Reiss-BrennanDaniel Ford
Sep 13, 2006·Administration and Policy in Mental Health·Paul A NuttingW Perry Dickinson
Nov 1, 2011·Community Mental Health Journal·Changsu HanJohn W Williams
Feb 3, 2009·Journal of Clinical Psychology in Medical Settings·Andrew S PomerantzMark J Detzer
Feb 25, 2009·Journal of Clinical Psychology in Medical Settings·Neil Korsen, Pam Pietruszewski
Apr 11, 2013·The Journal of Behavioral Health Services & Research·Yolonda R PickettWilliam Woolis
May 15, 2010·Journal of General Internal Medicine·Charles J Homer, Richard J Baron
Mar 9, 2011·Journal of General Internal Medicine·Gregory E SimonBelinda H Operskalski
Aug 7, 2012·Journal of General Internal Medicine·Paula P SchnurrVeronica Thurston
Mar 17, 2006·The New England Journal of Medicine·Charles F ReynoldsDavid J Kupfer
Oct 15, 2010·Aging & Mental Health·Christopher M CallahanHugh C Hendrie
Jul 26, 2011·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Thomas SheeranMartha L Bruce
Jun 1, 2008·Journal of Addiction Medicine·Richard SaitzJeffrey H Samet
Jan 6, 2009·Current Opinion in Psychiatry·Gregory Simon
Jul 14, 2006·Journal of General Internal Medicine·Lisa V RubensteinMartin L Lee
Sep 15, 2006·Journal of General Internal Medicine·Christopher M Callahan
Aug 19, 2011·International Journal of Clinical Practice·W W ChongT F Chen
May 23, 2007·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Andrew Kolbasovsky, Leonard Reich
May 24, 2007·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Lisa M LetourneauSusan Swartz
Sep 14, 2004·BMJ : British Medical Journal·Michael Von Korff
Feb 4, 2006·BMJ : British Medical Journal·Gregory Simon
Aug 18, 2012·Depression Research and Treatment·Barbara P YawnAllen J Dietrich
Sep 3, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Amy M BauerRichard G Frank
Apr 13, 2011·BMC Health Services Research·Jeffrey D FullerLyn Fragar
Mar 24, 2006·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Richard F HellerLesley Patterson
Jan 2, 2010·Implementation Science : IS·Edward P PostCharles F Reynolds
Feb 2, 2012·Implementation Science : IS·Gerdien FranxRichard Grol
Nov 23, 2011·International Journal of Mental Health Systems·Brian J KellySharon M Parker
Jul 11, 2012·Annals of Family Medicine·Barbara P YawnUNKNOWN TRIPPD practices

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.